Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.10.0.1
Note 14 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Revenues $ 8,062,000 $ 6,538,000 $ 22,717,000 $ 18,045,000
Operating income (loss) (191,302) (405,527) (730,769) (3,106,366)
Depreciation and amortization 389,269 468,800 1,181,661 1,550,013
Business Combination, Bargain Purchase, Gain Recognized, Amount 75,264
Other (expense) income, net (10,672) 9,907 (33,556) (33,589)
Loss before income tax expense (201,974) (395,620) (689,061) (3,139,955)
Operating Segments [Member]        
Operating income (loss) 2,570,000 1,447,000 6,385,000 2,670,000
Corporate, Non-Segment [Member]        
Operating income (loss) (2,761,000) (1,853,000) (7,116,000) (5,776,000)
Corporate Clinics [Member]        
Revenues 3,675,000 2,930,000 10,352,000 8,106,000
Operating income (loss) 440,000 (196,000) 466,000 (1,651,000)
Depreciation and amortization 276,000 379,000 825,000 1,222,000
Franchise Operations [Member]        
Revenues 4,387,000 3,608,000 12,365,000 9,939,000
Operating income (loss) 2,130,000 1,643,000 5,919,000 4,321,000
Depreciation and amortization
Corporate Segment [Member]        
Depreciation and amortization $ 113,000 $ 90,000 $ 357,000 $ 328,000